Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2224-2228

  Tsai, Hsiaoyun ^a   Bobek, Libuse A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTATIN; MICONAZOLE;

AMINO ACID SEQUENCE; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; DRUG PROTEIN BINDING; DRUG SENSITIVITY; FUNGICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030863427     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2224     Document Type: Article

References (37)

1. Baum, B. J., J. L. Bird, and R. W. Longton. 1977. Polyacrylamide gel electrophoresis of human salivary histidine-rich polypeptides. J. Dent. Res. 56: 1115-1118.
2. Budtz-Jorgensen, E. 1990. Candida-associated denture stomatitis and angular cheilitis, p. 156-183. In L. P. Samaranayake and T. W. MacFarlane (ed.), Oral candidosis. Butterworths, London, United Kingdom.
3. Cannon, R. D., A. R. Holmes, A. B. Mason, and B. C. Monk. 1995. Oral Candida: clearance, colonization, or candidiasis. J. Dent. Res. 74:1152-1161.
4. Deng, W. P., and J. A. Nickoloff. 1992. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-87.
5. Driscoll, J., Y. Zuo, T. Xu, R. R. Troxler, and F. G. Oppenheim. 1996. Investigation of the anticandidal mechanism of histatins. J. Dent. Res. 75:358. (Abstract 1751.)
6. Edgerton, M., T. Lo, and P. A. Raj. 1996. Salivary histatin-3 and histatin-5 exhibit specific binding to yeast cell membranes. J. Dent. Res. 75:358. (Abstract 2723.)
7. Greenfield, N., and G. D. Fasman. 1969. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8:4108-4116.
8. Joly, V., J. Bolard, and P. Yeni. 1992. In vitro models for studying toxicity of antifungal agents. Antimicrob. Agents Chemother. 36:1799-1804.
9. Jung, G., H. Bruckner, and H. Schmitt. 1981. Properties of the membrane modifying polypeptide antibiotics alamethicin and trichotoxin A-40, p. 75-114. In W. Voelter and G. Weitzel (ed.), Structure and activity of natural peptides. Walter de Gruyter, Berlin, Germany.
10. Kalb, V. F., J. C. Loper, C. R. Dey, C. W. Woods, and T. R. Sutter. 1986. Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae. Gene 45:237-245.
11. Kirkpatrick, C. H., I. Green, R. P. Rich, and A. L. Schade. 1971. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host defense mechanisms in chronic mucocutaneous candidiasis. J. Infect. Dis. 24:539-544.
12. Lal, K., R. P. Santarpia III, L. Xu, F. Manssuri, and J. J. Pollock. 1992. One-step purification of histidine-rich polypeptides from human parotid saliva and determination of anticandidal activity. Oral Microbiol. Immunol. 7:44-50.
13. Lal, K., J. J. Pollock, R. P. Santarpia III, H. M. Heller, H. W. Kaufman, F. Furhrer, and R. T. Steigbigel. 1992. Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J. Acquired Immune Defic. Syndr. 5:904-914.
14. MacKay, B. J., J. J. Pollock, V. J. Iacono, and B. J. Baum. 1984. Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. Infect. Immun. 44:688-694.
15. Mandel, I. D., C. E. Barr, and L. Turgeon. 1992. Longitudinal study of parotid saliva in HIV-1 infection. J. Oral Pathol. Med. 21:209-213.
16. Murakami, Y., H. Nagata, S. Shizukuishi, K. Nakashima, T. Okawa, M. Takigawa, and A. Tsunemitsu. 1994. Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation. Biochem. Biophys. Res. Commun. 198:274-280.
17. Nikawa, H., S. Hayashi, Y. Nikawa, and L. P. Samaranayake. 1993. Interactions between denture lining material, protein pellicles and Candida albicans. Arch. Oral Biol. 38:631-634.
18. Novagen, Inc. 1995. pET system manual, 6th ed. Novagen, Inc., Madison, Wis.
19. O'Connell, B. C., T. Xu, T. J. Walsh, T. Sein, A. Mastrangeli, R. G. Crystal, F. G. Oppenheim, and B. J. Baum. 1996. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum. Gene Ther. 7:2255-2261.
20. Odds, G. C. 1988. Candida and candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London, United Kingdom.
21. Oppenheim, F. G., T. Xu, F. M. McMillin, S. M. Levitz, R. D. Diamond, G. D. Offner, and R. F. Troxler. 1988. Histatins, a novel family of histidine-rich proteins in human parotid secretion. J. Biol. Chem. 263:7472-7477.
22. Peterson, D. E. 1992. Oral candidiasis. Clin. Geriatr. Med. 8:513-527.
23. Pollock, J. J., L. Denepitiya, B. J. MacKay, and V. J. Iacono. 1984. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect. Immun. 44:702-707.
24. Raj, P. A., M. Edgerton, and M. J. Levine. 1990. Salivary histatin-5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J. Biol. Chem. 265:3898-3905.
25. Raj, P. A., S. Soni, and M. J. Levine. 1994. Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins. J. Biol. Chem. 269:9610-9619.
26. Ramalingam, K., T. L. Gururaja, N. Ramasubbu, and M. J. Levine. 1996. Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity. Biochem. Biophys. Res. Commun. 225:47-53.
27. Rayhan, R., L. Xu, R. P. Santarpia III, C. A. Tylenda, and J. J. Pollock. 1992. Antifungal activities of salivary histide-rich polypeptides against Candida albicans and other oral yeast isolates. Oral Microbial. Immunol. 7:51-52.
28. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
29. Santarpia, R. P., III, E. C. Brant, K. Lal, M. M. Brasseur, A. L. Hong, and J. J. Pollock. 1988. A comparison of the inhibition of blastospore viability and germ-tube development in Candida albicans by histidine peptides and ketoconazole. Arch. Oral Biol. 33:567-573.
30. Sternberg, S. 1994. The emerging fungal threat. Science 266:1632-1634.
31. Tobgi, R. S., L. P. Samaranayake, and T. W. MacFarlane. 1987. The in vitro susceptibility of Candida species to lysozyme. Oral Microbiol. Immunol. 3:35-39.
32. Tsai, H., P. A. Raj, and L. A. Bobek. 1996. Candidacidal activity of recombinant human salivary histatin-5 and variants. Infect. Immun. 64:5000-5007.
33. Vanden Bossche, H., G. Willemsens, and P. Marichal. 1987. Anti-candida drugs - the biochemical basis for their activity. Crit. Rev. Microbiol. 15:57-72.
34. White, T. C. 1997. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans. Antimicrob. Agents Chemother. 41:1488-1494.
35. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
36. Xu, T., S. M. Levitz, R. D. Diamond, and F. G. Oppenheim. 1991. Anticandidal activity of major human salivary histatins. Infect. Immun. 59:2549-2554.
37. Zegarelli, E. V., A. H. Kutscher, R. E. Herlands, J. J. Lucca, and H. F. Silvers. 1961. Oral lesions of interest to the prosthodontist. Part I. Denture stomatitis. J. Prosthet. Dent. 11:617-620.